Table 3.
Spatial autoregressive model regression results across cause-specific YLL rates for the years 1990, 2000, 2010, and 2014
| Diabetes | All cause | |||||||
|---|---|---|---|---|---|---|---|---|
| 1990 | 2000 | 2010 | 2014 | 1990 | 2000 | 2010 | 2014 | |
| Continuous HOLC exposure | ||||||||
| HOLC grade (score 1–4) | 0.44 (0.36– 0.53)*** | 0.50 (0.43– 0.57)*** | 0.49 (0.41– 0.56)*** | 0.51 (0.43– 0.59)*** | 0.30 (0.24– 0.37)*** | 0.30 (0.25– 0.36)*** | 0.29 (0.24– 0.34)*** | 0.30 (0.24– 0.35)*** |
| No. of observations | 109 | 109 | 109 | 109 | 109 | 109 | 109 | 109 |
| Pseudo R2 | 0.53 | 0.59 | 0.53 | 0.51 | 0.54 | 0.58 | 0.52 | 0.51 |
| Binary HOLC exposure of A/B vs. C/D | ||||||||
| HOLC grade (A/B vs. C/D) | 0.75 (0.63– 0.87)*** | 0.81 (0.69– 0.92)*** | 0.78 (0.65– 0.90)*** | 0.81 (0.67– 0.94)*** | 0.48 (0.39– 0.58)*** | 0.47 (0.39– 0.56)*** | 0.45 (0.37– 0.53)*** | 0.46 (0.37– 0.54)*** |
| No. of observations | 109 | 109 | 109 | 109 | 109 | 109 | 109 | 109 |
| Pseudo R2 | 0.53 | 0.55 | 0.50 | 0.48 | 0.49 | 0.52 | 0.47 | 0.45 |
The outcome measure is age standardized (across all ages) and in logarithms. Robust 95% CIs are reported within the parentheses. Significance is denoted as follows:
P < 0.01.